Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

$LXEO stock is down 4% today. Here's what we see in our data.

None

$LXEO stock has now fallen 4% today, according to our price data from Polygon. There has been approximately $2,293,081 of trading volume.

It has been the 123rd most-searched ticker on Quiver Quantitative over the last day, out of 10,524 total tickers searched.

Here is what we see in our data on $LXEO (you can track the company live on Quiver's $LXEO stock page):

$LXEO Insider Trading Activity

LXEO Insider Trades

$LXEO insiders have traded $LXEO stock on the open market 20 times in the past 6 months. Of those trades, 0 have been purchases and 20 have been sales.

Here’s a breakdown of recent trading of $LXEO stock by insiders over the last 6 months:

  • RICHARD NOLAN TOWNSEND (Chief Executive Officer) has made 0 purchases and 4 sales selling 16,995 shares for an estimated $140,650.
  • TAI SANDI SEE (Chief Development Officer) has made 0 purchases and 4 sales selling 4,656 shares for an estimated $40,128.
  • JENNY ROBERTSON (Chief Legal Officer) has made 0 purchases and 4 sales selling 4,617 shares for an estimated $39,149.
  • JOSE MANUEL OTERO (Chief Technical Officer) has made 0 purchases and 4 sales selling 5,684 shares for an estimated $38,890.
  • ERIC ADLER (Chief Medical Officer) has made 0 purchases and 4 sales selling 4,605 shares for an estimated $38,781.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$LXEO Hedge Fund Activity

We have seen 77 institutional investors add shares of $LXEO stock to their portfolio, and 22 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$LXEO Analyst Ratings

Wall Street analysts have issued reports on $LXEO in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • HC Wainwright & Co. issued a "Buy" rating on 01/13/2026
  • Raymond James issued a "Strong Buy" rating on 12/18/2025
  • Cantor Fitzgerald issued a "Overweight" rating on 12/01/2025
  • Chardan Capital issued a "Buy" rating on 11/05/2025
  • Leerink Partners issued a "Outperform" rating on 10/07/2025
  • Oppenheimer issued a "Outperform" rating on 07/31/2025

To track analyst ratings and price targets for $LXEO, check out Quiver Quantitative's $LXEO forecast page.

$LXEO Price Targets

Multiple analysts have issued price targets for $LXEO recently. We have seen 7 analysts offer price targets for $LXEO in the last 6 months, with a median target of $20.0.

Here are some recent targets:

  • Mitchell S. Kapoor from HC Wainwright & Co. set a target price of $10.0 on 01/13/2026
  • Geulah Livshits from Chardan Capital set a target price of $17.0 on 01/13/2026
  • Christopher Raymond from Raymond James set a target price of $25.0 on 12/18/2025
  • Kristen Kluska from Cantor Fitzgerald set a target price of $19.0 on 12/01/2025
  • Debjit Chattopadhyay from Guggenheim set a target price of $30.0 on 10/15/2025
  • Mani Foroohar from Leerink Partners set a target price of $20.0 on 10/07/2025
  • Leland Gershell from Oppenheimer set a target price of $20.0 on 07/31/2025

You can track data on $LXEO on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles